Diagnostic and Therapeutic Technologies Research Group

Research Achievements

Multi-disciplinary translational research, especially applied to methods, technologies and materials to improve therapeutics and diagnostics is a major challenge. Many of the core members of the proposed Group were instrumental in contributing to defining strategic directions for Institutes such as ICaMB and ICM. All core members of the Group were involved in RAE 5 or 5* rated UoAs in the 2001 RAE. This success has been built upon and significant funding, from Research Councils, the EC, industry, the Ministry of Defence, charities and venture-capital funding for spin-out companies for both clinical and basic science has been obtained. By any research metric the Group is at the forefront of the field at an international level.

Research Strategy

The development of diagnostic and therapeutic technologies, including Nanomedicine, will be crucial over the next twenty years in delivering improved healthcare and patient management. Our own research vision is of a communicating interface between the physical and biological worlds; the engineered Biological-Physical-Information Interface. Over the next few years the Group will therefore expand the multi-disciplinary research capability within the University in both regional and international contexts. We will seek to broaden the scope and emphasis of the Group, and indeed the Institutes in which we are involved, in order to promote and encourage training and investment in biomedical application and clinical deployment of therapeutic technologies and diagnostic devices. It is envisaged that the networking of the Group within the wider University research context would extend the beneficiaries into the community at large by forming consortia to bid for national collaborative funding and funding from the EC Framwork 7 programme, within which healthcare and delivery is a major priority in a number of strategic programmes.

More information about this area of research can be found at the Institute of Cellular Medicine.

Staff List


Professor Mark Birch-Machin
(1) Associate Dean of Business Development and Commercial interface (2) Professor of Molecular Dermatology (3) Deputy Degree Programme Director MRes (Biotechnology) (4) Co-Founder:Genesis Genomics (now Mitomics) Inc (5) Co-Founder PB Bioscience Ltd

Professor Colin Harwood
Professor of Molecular Microbiology

Professor John Isaacs
Institute Director

  • Email: john.isaacs@ncl.ac.uk
  • Telephone: +44 (0) 191 208 5851 (Institute Business) +44 (0) 191 208 5337 (Research Matters)

Professor David Jones
Dean of Research & Innovation

Professor Jeremy Lakey
Professor of Structural Biochemistry

Dr Philip Langley

  • Telephone: +44 (0) 191 2823813

Dr Philip Manning

Professor Calum McNeil
Professor of Biological Sensor Systems

Professor Alan Murray
Professor of Cardiovascular Physics

Emeritus Professor Colin Self
Emeritus Professor

Professor Matthew Wright
Professor of Toxicology

>> Research Groups